New therapies in sickle cell disease
- 1 August 2002
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 360 (9333), 629-631
- https://doi.org/10.1016/s0140-6736(02)09776-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene TherapyScience, 2001
- Erythrocyte-active agents and treatment of sickle cell diseaseSeminars in Hematology, 2001
- Pharmacological induction of fetal hemoglobin in sickle cell disease and β-thalassemiaSeminars in Hematology, 2001
- Thrombogenesis in sickle cell diseaseJournal of Laboratory and Clinical Medicine, 2001
- Modulation of endothelial cell activation in sickle cell disease: a pilot studyBlood, 2001
- 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemiaBlood, 2000
- Blockade of Adhesion of Sickle Cells to Endothelium by Monoclonal AntibodiesNew England Journal of Medicine, 2000
- Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.Journal of Clinical Investigation, 1997
- Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.Journal of Clinical Investigation, 1996
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995